New approach aims to wipe out lung cancer before surgery

NCT ID NCT06788912

Summary

This study is testing whether giving new drug combinations before surgery can eliminate cancer cells in people with operable lung cancer. Researchers want to see if these treatments can completely clear cancer from tumors and lymph nodes removed during surgery. The study involves 60 participants with newly diagnosed, operable non-small cell lung cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NEOPLASM MALIGNANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • ATTIKON GENERAL UNIVERSITY HOSPITAL-Oncology ( Site 0202)

    RECRUITING

    Athens, Attica, 12462, Greece

    Contact Phone: •••-•••-••••

  • Alexandra General Hospital of Athens Oncology-Hematology Unit ( Site 0203)

    RECRUITING

    Athens, Attica, 115 28, Greece

    Contact Phone: •••-•••-••••

  • Azienda Ospedaliera Universitaria Careggi ( Site 0173)

    RECRUITING

    Florence, Tuscany, 50134, Italy

    Contact Phone: •••-•••-••••

  • Bradfordhill ( Site 0160)

    RECRUITING

    Santiago, Region M. de Santiago, 8420383, Chile

    Contact Phone: •••-•••-••••

  • CNCE Precarpathian Clinical Oncologic Center ( Site 0131)

    RECRUITING

    Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine

    Contact Phone: •••-•••-••••

  • CNE CC of Oncology Hematol ( Site 0130)

    RECRUITING

    Cherkasy, Cherkasy Oblast, 18009, Ukraine

    Contact Phone: •••-•••-••••

  • Centro de Estudios Clínicos SAGA ( Site 0162)

    RECRUITING

    Santiago, Region M. de Santiago, 7500653, Chile

    Contact Phone: •••-•••-••••

  • Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council" ( Site 0135)

    RECRUITING

    Vinnytsia, Vinnytsia Oblast, 21029, Ukraine

    Contact Phone: •••-•••-••••

  • FALP ( Site 0161)

    RECRUITING

    Santiago, Region M. de Santiago, 7500921, Chile

    Contact Phone: •••-•••-••••

  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0175)

    RECRUITING

    Milan, 20133, Italy

    Contact Phone: •••-•••-••••

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0174)

    RECRUITING

    Roma, 00168, Italy

    Contact Phone: •••-•••-••••

  • Hacettepe Universite Hastaneleri-oncology hospital ( Site 0700)

    RECRUITING

    Ankara, 06230, Turkey (Türkiye)

    Contact Phone: •••-•••-••••

  • Hospital Clínic de Barcelona ( Site 0092)

    RECRUITING

    Barcelona, 08008, Spain

    Contact Phone: •••-•••-••••

  • Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 0061)

    RECRUITING

    Szolnok, Jász-Nagykun-Szolnok, 5000, Hungary

    Contact Phone: •••-•••-••••

  • ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 0460)

    RECRUITING

    Rivne, Rivne Oblast, 33010, Ukraine

    Contact Phone: •••-•••-••••

  • MNPE LTMU Multidisc. Clin. Hosp. of Emerg. and Intens. Care ( Site 0132)

    RECRUITING

    Lviv, Lviv Oblast, 79059, Ukraine

    Contact Phone: •••-•••-••••

  • MedStar Franklin Square Medical Center ( Site 0033)

    RECRUITING

    Baltimore, Maryland, 21237, United States

    Contact Phone: •••-•••-••••

  • Metropolitan Hospital-4th Oncology Dept ( Site 0201)

    RECRUITING

    Athens, Attica, 185 47, Greece

    Contact Phone: •••-•••-••••

  • Municipal Enterprise "Bukovinian сlinical oncology сenter" ( Site 0139)

    RECRUITING

    Chernivtsi, Chernivetska Oblast, 58013, Ukraine

    Contact Phone: •••-•••-••••

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 0151)

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-781, Poland

    Contact Phone: •••-•••-••••

  • Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8006)

    RECRUITING

    Eugene, Oregon, 97401, United States

    Contact Phone: •••-•••-••••

  • Országos Korányi Pulmonológiai Intézet ( Site 0060)

    RECRUITING

    Budapest, 1121, Hungary

    Contact Phone: •••-•••-••••

  • Ospedale San Raffaele. ( Site 0171)

    RECRUITING

    Milan, 20132, Italy

    Contact Phone: •••-•••-••••

  • Petz Aladar Egyetemi Oktato Korhaz-Pulmonológia (Dr. Szalai Zsuzsanna) ( Site 0062)

    RECRUITING

    Győr, Győr-Moson-Sopron, 9024, Hungary

    Contact Phone: •••-•••-••••

  • Sansum Clinic (Ridley Tree) ( Site 8012)

    RECRUITING

    Santa Barbara, California, 93105, United States

    Contact Phone: •••-•••-••••

  • Shalimov Institute of Surgery and Transplantation ( Site 0138)

    RECRUITING

    Kyiv, 03126, Ukraine

    Contact Phone: •••-•••-••••

  • Southern Cancer Center (SCC) ( Site 8004)

    RECRUITING

    Daphne, Alabama, 36526, United States

    Contact Phone: •••-•••-••••

  • University General Hospital of Heraklion ( Site 0200)

    RECRUITING

    Heraklion, Irakleio, 71110, Greece

    Contact Phone: •••-•••-••••

  • Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)

    RECRUITING

    Gdansk, Pomeranian Voivodeship, 80-952, Poland

    Contact Phone: •••-•••-••••

  • Virginia Cancer Specialists (VCS) ( Site 8002)

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-••••

  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 0153)

    RECRUITING

    Poznan, Greater Poland Voivodeship, 60-569, Poland

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.